LENZ Therapeutics, Inc.
LENZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815776
No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in LENZ Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- +51 vs. Q1 2021
- Shares held
- 32.2M
- +32.2M vs. Q1 2021
- Total value
- $981.4M
- +$981.4M vs. Q1 2021
- New holders
- 51
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LENZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 145 | $197.3M |
| Q1 2026 | 146 | $303.3M |
| Q4 2025 | 161 | $561.6M |
| Q3 2025 | 166 | $1.36B |
| Q2 2025 | 114 | $725.1M |
| Q1 2025 | 105 | $541.8M |
| Q4 2024 | 95 | $573.2M |
| Q3 2024 | 78 | $444.8M |
| Q2 2024 | 65 | $327.0M |
| Q1 2024 | 55 | $362.0M |
| Q4 2023 | 63 | $81.5M |
| Q3 2023 | 67 | $75.8M |
| Q2 2023 | 66 | $81.2M |
| Q1 2023 | 62 | $72.9M |
| Q4 2022 | 66 | $95.6M |
| Q3 2022 | 63 | $93.9M |
| Q2 2022 | 63 | $83.0M |
| Q1 2022 | 63 | $185.7M |
| Q4 2021 | 58 | $431.7M |
| Q3 2021 | 60 | $587.4M |
| Q2 2021 | 51 | $981.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding LENZ Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 32 | $1.00K | 0.00% | +32 | New |
| Bank of America Corp | 200 | $6.00K | 0.00% | +200 | New |
| Point72 Hong Kong Ltd | 2,576 | $79.0K | 0.01% | +2,576 | New |
| Virtu Financial LLC | 7,709 | $237.0K | 0.02% | +7,709 | New |
| Point72 Asset Management, L.P. | 10,000 | $307.0K | 0.00% | +10,000 | New |
| Tudor Investment Corp Et Al | 12,000 | $369.0K | 0.01% | +12,000 | New |
| Maven Securities LTD | 12,500 | $389.0K | 0.04% | +12,500 | New |
| Qube Research & Technologies Ltd | 14,700 | $452.0K | 0.01% | +14,700 | New |
| Jane Street Group, LLC | 15,225 | $468.0K | 0.00% | +15,225 | New |
| Balyasny Asset Management LLC | 19,232 | $591.0K | 0.00% | +19,232 | New |
| Voloridge Investment Management, LLC | 20,000 | $615.0K | 0.00% | +20,000 | New |
| Sphera Funds Management Ltd. | 24,957 | $767.0K | 0.07% | +24,957 | New |
| Davidson Kempner Capital Management LP | 25,000 | $768.0K | 0.01% | +25,000 | New |
| Vanguard Group Inc | 30,000 | $921.0K | 0.00% | +30,000 | New |
| Alyeska Investment Group, L.P. | 30,000 | $922.0K | 0.01% | +30,000 | New |
| Marshall Wace North America L.P. | 36,646 | $1.13M | 0.00% | +36,646 | New |
| Squarepoint Ops LLC | 40,000 | $1.23M | 0.01% | +40,000 | New |
| Caas Capital Management LP | 40,000 | $1.23M | 0.07% | +40,000 | New |
| Ghisallo Capital Management LLC | 40,000 | $1.23M | 0.05% | +40,000 | New |
| Asymmetry Capital Management, L.P. | 51,039 | $1.57M | 1.08% | +51,039 | New |
| Pinz Capital Management, LP | 52,543 | $1.61M | 0.49% | +52,543 | New |
| Monashee Investment Management LLC | 60,000 | $1.84M | 0.22% | +60,000 | New |
| LMR Partners LLP | 70,000 | $2.15M | 0.03% | +70,000 | New |
| Blackstone Group Inc. | 75,000 | $2.31M | 0.01% | +75,000 | New |
| BlackRock Inc. | 103,581 | $3.18M | 0.00% | +103,581 | New |
| Suvretta Capital Management, LLC | 125,000 | $3.84M | 0.06% | +125,000 | New |
| Cormorant Asset Management, LP | 203,153 | $5.93M | 0.23% | +203,153 | New |
| Morgan Stanley | 263,502 | $8.10M | 0.00% | +263,502 | New |
| Goldman Sachs Group Inc | 274,426 | $8.43M | 0.00% | +274,426 | New |
| Jennison Associates LLC | 300,000 | $9.22M | 0.01% | +300,000 | New |
| Adage Capital Partners GP, L.L.C. | 300,000 | $9.22M | 0.02% | +300,000 | New |
| Woodline Partners LP | 309,723 | $9.52M | 0.18% | +309,723 | New |
| UBS Asset Management Americas Inc | 393,787 | $12.1M | 0.01% | +393,787 | New |
| Millennium Management LLC | 589,833 | $18.1M | 0.02% | +589,833 | New |
| Federated Hermes, Inc. | 650,000 | $20.0M | 0.04% | +650,000 | New |
| Artal Group S.A. | 700,000 | $21.5M | 0.49% | +700,000 | New |
| Norges Bank | 700,000 | $21.5M | 0.00% | +700,000 | New |
| Board of Trustees of The Leland Stanford Junior University | 703,701 | $21.6M | 2.02% | +703,701 | New |
| Avidity Partners Management LP | 735,500 | $22.6M | 0.61% | +735,500 | New |
| Perceptive Advisors LLC | 875,093 | $26.9M | 0.35% | +875,093 | New |
| Deerfield Management Company, L.P. (Series C) | 906,308 | $27.9M | 0.49% | +906,308 | New |
| SB Management Ltd | 993,402 | $30.5M | 0.36% | +993,402 | New |
| Logos Global Management LP | 1,070,762 | $32.9M | 2.82% | +1,070,762 | New |
| OrbiMed Advisors LLC | 1,106,307 | $34.0M | 0.35% | +1,106,307 | New |
| Janus Henderson Group PLC | 1,251,005 | $36.7M | 0.02% | +1,251,005 | New |
| Citadel Advisors LLC | 1,288,225 | $38.9M | 0.04% | +1,288,225 | New |
| VR Adviser, LLC | 1,612,617 | $49.6M | 6.01% | +1,612,617 | New |
| Rock Springs Capital Management LP | 2,151,738 | $66.1M | 1.31% | +2,151,738 | New |
| Ra Capital Management, L.P. | 2,698,369 | $82.9M | 1.33% | +2,698,369 | New |
| FMR LLC | 3,761,979 | $110.6M | 0.01% | +3,761,979 | New |
| Samsara BioCapital, LLC | 7,431,623 | $228.4M | 30.02% | +7,431,623 | New |